Suppr超能文献

无晶状体眼后房型人工晶状体植入术后纤维蛋白膜瞳孔阻滞性青光眼应用前房内组织型纤溶酶原激活物治疗 1 例

Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.

机构信息

Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahi-machi, Niigata-shi 951-8120, Japan.

出版信息

BMC Ophthalmol. 2012 Mar 20;12:3. doi: 10.1186/1471-2415-12-3.

Abstract

BACKGROUND

Fibrin pupillary-block glaucoma is a rare complication after cataract surgery. The treatment for this condition is still controversial, since Nd:YAG laser fibrin membranotomy tends to reocclude and laser peripheral iridotomy entails the risk of damaging the corneal endothelium in the presence of corneal edema associated with elevated intraocular pressure.

CASE PRESENTATION

A 62-year-old man with diabetes mellitus developed acute elevation of intraocular pressure with a shallow anterior chamber five days after uneventful cataract surgery. Initially, slit lamp examination provided only limited information due to severe corneal edema. After resolution of corneal edema with systemic glaucoma therapy, a complete fibrin membrane was observed across the pupil by slit lamp examination. Anterior segment optic coherence tomography clearly revealed a thin fibrin membrane covering the entire pupillary space, a shallow anterior chamber, and a deep posterior chamber. The intraocular lens was not observed by anterior segment optic coherence tomography. In contrast, ultrasound biomicroscopy, which has superior penetration depth, was able to visualize the intraocular lens deep in the posterior chamber. Injection of tissue plasminogen activator into the anterior chamber resulted in complete fibrinolysis and released the pupillary block.

CONCLUSION

This case suggests that ocular anterior segment imaging modalities, especially ultrasound biomicroscopy, serve as powerful diagnostic tools to identify mechanisms of acute angle closure glaucoma, which is often accompanied by poor intraocular visibility. This is the first reported case of fibrin pupillary-block glaucoma after cataract surgery successfully treated with intracameral tissue plasminogen activator.

摘要

背景

纤维蛋白瞳孔阻滞性青光眼是白内障手术后罕见的并发症。对于这种情况的治疗仍然存在争议,因为 Nd:YAG 激光纤维蛋白膜切开术往往会再次阻塞,而激光周边虹膜切开术在与眼压升高相关的角膜水肿存在的情况下,有损伤角膜内皮的风险。

病例介绍

一位 62 岁的糖尿病男性患者在白内障手术后五天出现急性眼压升高和浅前房。最初,由于严重的角膜水肿,裂隙灯检查仅提供了有限的信息。在通过全身青光眼治疗缓解角膜水肿后,通过裂隙灯检查观察到整个瞳孔上有完整的纤维蛋白膜。眼前段光学相干断层扫描清楚地显示出覆盖整个瞳孔空间、浅前房和深后房的薄纤维蛋白膜。眼前段光学相干断层扫描未观察到人工晶状体。相比之下,具有更好穿透深度的超声生物显微镜能够在深后房可视化人工晶状体。在前房注射组织纤溶酶原激活剂导致完全纤维蛋白溶解,并释放瞳孔阻滞。

结论

本病例提示眼前节成像方式,尤其是超声生物显微镜,是一种强大的诊断工具,可以识别急性闭角型青光眼的机制,这种青光眼通常伴有较差的眼内可视度。这是首例成功用前房内组织纤溶酶原激活剂治疗白内障手术后纤维蛋白瞳孔阻滞性青光眼的报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f8/3326710/9c6cb4fc5025/1471-2415-12-3-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验